OTC pain and fever reducers (acetaminophen / NSAIDs)
Audience: Pharmacists, other healthcare professionals, and consumers
The FDA notified healthcare professionals of a national education campaign to provide advice on the safe use of over-the-counter (OTC) pain and fever reducers that contain acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs). The campaign is intended to raise consumer awareness of these safety issues and to inform healthcare providers about the role that they can play in preventing acetaminophen induced hepatotoxicity and NSAID-related gastrointestinal bleeding and renal toxicity in patients using these medicines.
[January 22, 2004 - Drug Information Page - FDA]
[January 22, 2004 - Science Backgrounder - FDA]
[January 22, 2004 - Letter to State Boards of Pharmacy - FDA]
[January 22, 2004 - Press Release - FDA]